Skip to main content
SpringerLink
Log in

Antipsychotics: examining the risk of OCD

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Burk BG, et al. Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system. Acta Psychiatrica Scandinavica : 17 May 2023. Available from: URL: https://doi.org/10.1111/acps.13567

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antipsychotics: examining the risk of OCD. Reactions Weekly 1959, 9 (2023). https://doi.org/10.1007/s40278-023-40181-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-40181-z

Search

Navigation